Does GOLIMUMAB Cause C-reactive protein abnormal? 1,923 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,923 reports of C-reactive protein abnormal have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 2.8% of all adverse event reports for GOLIMUMAB.
1,923
Reports of C-reactive protein abnormal with GOLIMUMAB
2.8%
of all GOLIMUMAB reports
979
Deaths
1,483
Hospitalizations
How Dangerous Is C-reactive protein abnormal From GOLIMUMAB?
Of the 1,923 reports, 979 (50.9%) resulted in death, 1,483 (77.1%) required hospitalization, and 1,088 (56.6%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 1,923 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which GOLIMUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN